Why the study?
The direct impact of hospital accreditation on patients' clinical outcomes is unclear.
Does hospital accreditation reduce 30-day mortality in patients hospitalized for major cardiovascular diseases?
Does hospital accreditation reduce 30-day mortality in patients hospitalized for major cardiovascular diseases?
Hospital accreditation is associated with a significant reduction in 30-day in-hospital mortality for patients admitted with acute myocardial infarction and stroke.
Should not yet change practice or referral; leaves open whether accreditation causally lowers AMI and stroke mortality.
The direct impact of hospital accreditation on patients' clinical outcomes is unclear. The purpose of this study was to evaluate whether mortality within 30 days of hospitalization for acute myocardial infarction (AMI), ischemic stroke (IS), and hemorrhagic stroke (HS) differed before and after hospital accreditation. This study targeted patients who had been hospitalized for the three diseases at the general hospitals newly accredited by the government in 2014. Thirty-day mortality rates of three years before and after accreditation were compared. Mortality within 30 days of hospitalization for the three diseases was lower after accreditation than before (7.34% vs. 6.15% for AMI; 4.64% vs. 3.80% for IS; and 18.52% vs. 15.81% for HS). In addition, hospitals that meet the criteria of the patient care process domain have a statistically lower mortality rate than hospitals that do not. In the newly accredited Korean general hospital, it was confirmed that in-hospital mortality rates of major cardiovascular diseases were lower than before the accreditation.
No takes yet. Share an insight, caveat, or question.
Chun et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: